Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 78, Issue 1, 2011, Pages 75-82

  Geissler, Stefanie ^a   Hellwig, Michael ^b   Markwardt, Fritz ^a   Henle, Thomas ^b   Brandsch, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

3 Hydroxy 4 pyridinone; Intestine; Iron chelator; Maillard reaction; PEPT1; Prodrug

Indexed keywords

ALANYLMALTOSINE; AMINO ACID TRANSPORTER; DIPEPTIDE; IRON CHELATE; LYSINE; MALTOSINE; MALTOSINYLALANINE; PEPTIDE TRANSPORTER 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL INTERACTION; CELL STRAIN CACO 2; CELL TRANSPORT; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TRANSPORT; ELECTROPHYSIOLOGY; EPITHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; INTESTINE; NONHUMAN; OOCYTE; PROTEIN EXPRESSION;

CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPEPTIDES; HUMANS; IRON CHELATING AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NORLEUCINE; PYRIDONES;

EID: 79953164782     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.12.032     Document Type: Article

References (30)

1. G. Faa, and G. Crisponi Iron chelating agents in clinical practice Coord. Chem. Rev. 184 1999 291 310
2. M.A. Santos Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications: mono and combined ligand approaches Coord. Chem. Rev. 252 2008 1213 1224
3. A. Shander, M.D. Cappellini, and L.T. Goodnough Iron overload and toxicity: the hidden risk of multiple blood transfusions Vox Sang. 97 2009 185 197
4. A. Cao, and R. Galanello Beta-thalassemia Genet. Med. 12 2010 61 76
5. G. Crisponi, and M. Remelli Iron chelating agents for the treatment of iron overload Coord. Chem. Rev. 252 2007 1225 1240
6. N.F. Olivieri, J.R. Buncic, E. Chew, T. Gallant, R.V. Harrison, N. Keenan, W. Logan, D. Mitchell, G. Ricci, and B. Skarf Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions N. Engl. J. Med. 314 1986 869 873 (Pubitemid 16126113)
7. 67Ga J. Biol. Inorg. Chem. 10 2005 564 580 (Pubitemid 41400745)
8. G.J. Kontoghiorghes New orally active iron chelators Lancet 1 1985 817 (Pubitemid 15103892)
9. G.J. Kontoghiorghes, M.A. Aldouri, L. Sheppard, and A.V. Hoffbrand 1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload Lancet 1 1987 1294 1295 (Pubitemid 17072195)
10. G.J. Kontoghiorghes, M.A. Aldouri, A.V. Hoffbrand, J. Barr, B. Wonke, T. Kourouclaris, and L. Sheppard Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one Br. Med. J. 295 1987 1509 1512 (Pubitemid 18009747)
11. F. Ledl, H. Osiander, O. Pachmayr, and T. Severin Formation of maltosine, a product of the Maillard reaction with a pyridone structure Z. Lebensm. Unters. Forsch. A 188 1989 207 211
12. G. Rehner, and T. Walter Effect of Maillard products and lysinoalanine on the bioavailability of iron, copper and zinc Z. Ernährwiss. 30 1991 50 55
13. J. O'Brien, and P.A. Morrissey Metal ion complexation by products of the Maillard reaction Food Chem. 58 1997 17 27 (Pubitemid 27036076)
14. L.D. Stegink, J.B. Freeman, L. Den Besten, and L.J. Filer Maillard reaction products in parenteral nutrition Prog. Food Nutr. Sci. 5 1981 265 278
15. S. Seifert, R. Krause, K. Gloe, and T. Henle Studies on the metal complexation of the peptide-bound Maillard reaction products N-fructoselysine and N-carboxymethyllysine J. Agric. Food Chem. 52 2004 2347 2350
16. T. Henle, A.W. Walter, and H. Klostermeyer Simultaneous determination of protein-bound Maillard products by ion-exchange chromatography and photodiode array detection T.P. Labuza, Maillard Reactions in Chemistry, Food, and Health 1994 The Royal Society of Chemistry Cambridge, UK 195 200
17. S. Seifert, Synthese und Komplexbildungseigenschaften ausgewählter Maillard-Reaktionsprodukte, PhD thesis, TU Dresden, 2008.
18. M. Hellwig, S. Geissler, A. Peto, I. Knütter, M. Brandsch, and T. Henle Transport of free and peptide-bound pyrraline at intestinal and renal epithelial cells J. Agric. Food Chem. 57 2009 6474 6480
19. S. Geissler, M. Hellwig, M. Zwarg, F. Markwardt, T. Henle, and M. Brandsch Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1 J. Agric. Food Chem. 58 2010 2543 2547
20. T. Henle, A.W. Walter, and H. Klostermeyer A simple method for the preparation of furosine and pyridosine reference material Z. Lebensm. Unters. Forsch. 198 1994 66 67
21. M.A. Glomb, and C. Pfahler Amides are novel protein modifications formed by physiological sugars J. Biol. Chem. 276 2001 41638 41647
22. +/peptide transporters revisited J. Pharmacol. Exp. Ther. 327 2008 432 441
23. +/peptide transporters Drug Metab. Dispos. 37 2009 143 149
24. M. Dorn, M. Jaehme, M. Weiwad, F. Markwardt, R. Rudolph, M. Brandsch, and E. Bosse-Doenecke The role of N-glycosylation in transport function and surface targeting of the human solute carrier PAT1 FEBS Lett. 583 2009 1631 1636
25. T. Riedel, I. Lozinsky, G. Schmalzing, and F. Markwardt Kinetics of P2X7 receptor-operated single channels currents Biophys. J. 92 2007 2377 2391 (Pubitemid 46536420)
26. P.S. Dobbin, R.C. Hider, A.D. Hall, P.D. Taylor, P. Sarpong, J.B. Porter, G. Xiao, and D. van der Helm Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential J. Med. Chem. 36 1993 2448 2458 (Pubitemid 23270794)
27. W. Bannwarth, and R. Knorr Formation of carboxamides with N,N,N′,N′-tetramethyl (succinimido) uronium tetrafluoroborate in aqueous/organic solvent systems Tetrahedron Lett. 32 1991 1157 1160
28. M. Brandsch Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls Expert Opin. Drug Metab. Toxicol. 5 2009 887 905
29. I. Knütter, B. Hartrodt, S. Theis, M. Foltz, M. Rastetter, H. Daniel, K. Neubert, and M. Brandsch Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1 Eur. J. Pharm. Sci. 21 2004 61 67 (Pubitemid 38050204)
30. R. Tateoka, H. Abe, S. Miyauchi, S. Shuto, A. Matsuda, M. Kobayashi, K. Miyazaki, and N. Kamo Significance of substrate hydrophobicity for recognition by an oligopeptide transporter (PEPT1) Bioconjugate Chem. 12 2001 485 492 (Pubitemid 32696221)